Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1986-07-30
1992-11-10
Draper, Garnett D.
Drug, bio-affecting and body treating compositions
Lymphokine
514 8, 514 2, 424 92, 530395, 530351, 930145, A61K 3702
Patent
active
051621118
ABSTRACT:
Subjects suffering from infectious diseases are treated by direct administration of therapeutically-effective quantities of granulocyte-macrophage colony stimulating factor employed by itself or in conjunction with an antibiotic or a sulfonamide or other immunologically effective therapeutic agents. Homogeneous granulocyte-macrophage colony stimulating factor for use in treatment in bacterial diseases is prepared by recombinant DNA techniques and then purified to homogeneity by reverse phase high-performance liquid chromatography so that it may be safely administered to subject's suffering from infectious diseases.
REFERENCES:
patent: 4621050 (1986-11-01), Sugimoto
Donahue et al, Blood 66(6) 1985, pp. 479-481.
Seiff et al, Science 230, 1985, pp. 1171-1173.
Handman and Burgess, "Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages," J. Immunol. 122:1223 (1979).
Nozawa et al., "Stimulation by conditioned medium of L-929 fibroblasts, E. coli lipopolysaccharide, and muramyl dipeptide of candidacidal activity of mouse macrophages," Cell. Immunol. 53:116 (1980).
Ralph et al., "Colony-stimulating factors and regulation of macrophage tumoricidal and microbicidal activities," Cell. Immunol. 76:10 (1983).
Weisbart et al., "Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator," Nature 314:361 (1985).
Fleischmann et al., "Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils," Blood 68:708 (1986).
Mayer et al., "Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates," Blood 70:206 (1987).
Burgess and Metcalf, "The Nature and Action of Granulocyte-Macrophage Colony Stimulating Factors", Blood 56:947 (1980).
Gasson et al., "Purified Human Granulocyte-Macrophage Colony-Stimulating Factor: Direct Action on Neutrophils", Science 226:1339 (1984).
Weisbart et al., "Human Granulocyte-Macrophage Colony-Stimulating Factor is a Neutrophil Activator", Nature 314:361 (1985).
Cantrell et al., "Cloning, Sequence, and Expression of a Human Granulocyte/Macrophage Colony-Stimulating Factor", Proc. Natl. Acad. Sci. U.S.A. 82:6250 (1985).
Metcalf et al., "Biologic Properties In Vitro of a Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor", Blood 67:37 (1986).
Metcalf, "The Molecular Biology and Functions of the Granulocyte-Macrophage Colony-Stimulating Factors", Blood 67:257 (1986).
Grabstein et al., "Induction of Macrophage Tumoricidal Activity by Granulocyte-Macrophage Colony-Stimulating Factor", Science 232:506 (1986).
Grabstein Kenneth H.
Morrissey Philip J.
Draper Garnett D.
Hallquist Scott G.
Wight Christopher L.
LandOfFree
Treatment of bacterial diseases with granulocyte-macrophage colo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of bacterial diseases with granulocyte-macrophage colo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of bacterial diseases with granulocyte-macrophage colo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2291124